Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)

BACKGROUND: Renal anemia is an important complication in non-dialysis chronic kidney disease (CKD) patients as well as in dialysis patients. Although recombinant human erythropoietin has dramatically improved prognosis and quality of life in these patients, there have been issues among non-dialysis...

Full description

Saved in:
Bibliographic Details
Published in:Clin Exp Nephrol
Main Authors: Kato, Hideki, Nangaku, Masaomi, Hirakata, Hideki, Wada, Takashi, Hayashi, Terumasa, Sato, Hiroshi, Yamazaki, Yasushi, Masaki, Takao, Kagimura, Tatsuo, Yamamoto, Hiroyasu, Hase, Hiroki, Kamouchi, Masahiro, Imai, Enyu, Mizuno, Kyoichi, Iwasaki, Manabu, Akizawa, Tadao, Tsubakihara, Yoshiharu, Maruyama, Shoichi, Narita, Ichiei
Format: Artigo
Language:Inglês
Published: Springer Japan 2017
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805810/
https://ncbi.nlm.nih.gov/pubmed/28660446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-017-1427-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items